Clinical trial
The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism
NCT02216721 is registered in ClinicalTrials.gov with University Malaysia Sarawak as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism
- Lead sponsor
- University Malaysia Sarawak
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- May 31, 2015
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary aldosteronism